Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01120860 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator Performance
A clinical trial, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- 67
- Enrollment target
NCT01120860: Completed study, sponsored by Palo Alto Veterans Institute for Research.
NCT01120860 is a clinical trial that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01120860 has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
The primary purpose of this study is to apply state-of-the-art Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopic Imaging (MRSI) techniques to measure changes over time in the brain.
Primary Outcome
z-score composite of executing ATC communications, avoiding traffic, monitoring engine malfunctions, visual approach and landing
Interventions
- DEVICE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2002-11 |
| Est. Completion | 2011-07 |
What the finished NCT01120860 record still lists
NCT01120860 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 67 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT01120860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01120860 about?
NCT01120860 is a clinical study titled "Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator Performance". The primary purpose of this study is to apply state-of-the-art Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopic Imaging (MRSI) techniques to measure changes over time in the brain.
What is the current status of trial NCT01120860?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2002-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01120860?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT01120860?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia